arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Cardiff Lexington Corp

CDIX
Price unavailable
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
21 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
75
Health
Good
Moderately Bullish
auto_awesome

Analytical Summary

Cardiff Lexington Corp demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap
Dividend Yield
Revenue Growth 39.5%
Op. Margin 9.5%
ROIC 6.8%
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -7.52
info Valuation on last close.

21-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$11.54M
↑ +39.5%
Net Income Profit after all expenses
$-5.51M
↓ -66.7%
Operating Margin Operating profit as % of sales
9.5%
↑ +507.8% 55th
FCF / Share Free cash flow per share
$-0.10
↓ -1422.9%
Long-Term Debt Long-term obligations
$18.56M
↑ +101.5%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
31
Returns
100
Financial Health
98

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 21 years · 76 quarters